1CM INC. - Asset Resilience Ratio
1CM INC. (IQ70) has an Asset Resilience Ratio of 1.56% as of November 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read IQ70 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2025)
This chart shows how 1CM INC.'s Asset Resilience Ratio has changed over time. See what is 1CM INC.'s book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down 1CM INC.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 1CM INC. market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €669.80K | 1.56% |
| Total Liquid Assets | €669.80K | 1.56% |
Asset Resilience Insights
- Limited Liquidity: 1CM INC. maintains only 1.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
1CM INC. Industry Peers by Asset Resilience Ratio
Compare 1CM INC.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
Drug Manufacturers - Specialty & Generic | -2.56% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 18.70% |
Annual Asset Resilience Ratio for 1CM INC. (2024–2025)
The table below shows the annual Asset Resilience Ratio data for 1CM INC..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-08-31 | 1.60% | €669.80K ≈ $783.07K |
€41.86 Million ≈ $48.94 Million |
-- |
| 2024-08-31 | 0.00% | €0.00 ≈ $0.00 |
€39.87 Million ≈ $46.61 Million |
-- |
About 1CM INC.
1CM Inc., a multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada. The company operates cannabis and liquor retail stores. It also offers One Cannabis Market, a technology platform that provides B2B and B2C solutions, including last mile delivery, digital signage, big data analytics, and wholesale clearing services. The company … Read more